✦ LIBER ✦

133 oral A phase 3 study of neo-adjuvant Taxotere for radically-treatable stage III NSCLC

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early results of an international phase

✍ Mattson, K; Ten Velde, G; Krofta, K; Cour-Chabernaud, V; Abratt, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Docetaxel as neo-adjuvant therapy for ra

✍ Mattson, K; Abratt, R; Ten, G.Velde; Krofta, K; Tonelli, D; Avril, I 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 115 KB

O-113 Cisplatin plus gemcitabine with or

✍ Esteban, E.; Fernández, Y.; Vieitez, J.; Villanueva, N.; De Sande, J.; Fra, J.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Subcutaneous versus intravenous administ

✍ Gustavo Ismael; Roberto Hegg; Susanne Muehlbauer; Dominik Heinzmann; Bert Lum; S 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 245 KB

O-183 A phase III study of surgical rese

✍ Perry, Michael C.; Kohman, Leslie J.; Bonner, James A.; Zhang, Chunfeng; Herndon 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 185 KB

6514 ORAL Adjuvant therapy in stage IB/I

✍ Vansteenkiste, J.; Zielinski, M.; Linder, A.; Dahabre, J.; Esteban, E.; Malinows 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB